Photo = Reuters
–
The U.S. Food and Drug Administration (FDA) has proposed a solution to address the shortage of vaccines for the novel coronavirus infection (Corona 19). The guidelines have been set so that the remaining amount of the vaccine bottle can be used.
According to foreign media such as Politico on the 16th (local time), the Food and Drug Administration (FDA) has made it possible to use the remainder of the corona 19 vaccine bottle. Pfizer, a vaccine developer, received these instructions late this afternoon.
Accordingly, the supply of vaccines, which are in short supply, is expected to increase by up to 40%.
The Pfizer vaccine, which started on the 14th across the United States, officially contains five doses per bottle.
However, as a result of checking at a pharmacy, it was found that 6 to 7 doses of vaccine were contained per bottle. Accordingly, it is said that the use of residual vaccines will be of great help in resolving the supply-demand imbalance.
Usually, pharmaceutical companies inject a sufficient amount in the vaccine bottle beyond the threshold. This is to prepare for the possibility of spilling or spilling during the vaccination process.
However, it is known that pharmacies are confused because new guidelines have not been announced at the federal level.
Sharon Castillo, Pfizer’s public relations officer, said, “It is difficult to state at the moment on the treatment of the remaining amount.”
Reporter Chae Sun-hee [email protected]
–
Ⓒ Hankyung.com prohibits unauthorized reproduction and redistribution
–
